Azar names new senior advisor on drug pricing
Health and Human Services Secretary Alex Azar today named as his senior advisor for drug pricing reform John O’Brien, a pharmacist who previously served as deputy assistant secretary for health policy and an advisor on health reform and drug pricing. He replaces Daniel Best, who died last month. “John O’Brien has already been an integral leader in HHS’s efforts to bring down the high price of prescription drugs,” Azar said. “As a senior advisor, he will carry forward the legacy of our departed colleague Dan Best and build on the substantial progress that has already been made.” Before joining HHS, O’Brien was vice president of public policy for CareFirst BlueCross BlueShield.
Related News Articles
Headline
The Senate April 3 by a vote of 53-45 confirmed Mehmet Oz as the new administrator for the Centers for Medicare & Medicaid Services.
Headline
The Senate March 25 confirmed Marty Makary as the new commissioner of the Food and Drug Administration and Jay Bhattacharya as the new director of the National…
Headline
Tom Engels is the new administrator for the Health Resources and Services Administration, according to its website. Engels previously held the same position in…
Headline
Health and Human Services Secretary Xavier Becerra Jan. 8 appointed as chief competition officer Stacy Sanders, who currently oversees the department's…
Headline
President Biden intends to appoint as the next Centers for Disease Control and Prevention director Mandy Cohen, M.D., who served as secretary of the North…
Headline
The Government Accountability Office May 26 announced the appointment of five new members to the Medicare Payment Advisory Commission, along with two…